These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6453169)

  • 41. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
    Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
    Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The in vitro spectrum of the cephalosporins.
    Washington JA
    Mayo Clin Proc; 1976 Apr; 51(4):237-50. PubMed ID: 1263595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefuroxime, cefamandole, cefoxitin, and cephalothin in vitro susceptibility tests: reassessment of the "class representative" concept, confirmation of disk interpretive criteria, and proposed quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    Am J Clin Pathol; 1983 Aug; 80(2):182-9. PubMed ID: 6881092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antimicrobial resistance and resistance transfer in anaerobic. A review.
    Tally FP; Malamy MH
    Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standardization of antimicrobial disc susceptibility test for anaerobic bacteria.
    Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1976 Dec; 9(3-4):55-62. PubMed ID: 1037535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of BU-2313B against anaerobic bacteria.
    Bansal MB; Dhawan VK; Thadepalli H
    Chemotherapy; 1982; 28(3):200-3. PubMed ID: 6920296
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol.
    Cordero-Laurent E; Rodríguez C; Rodríguez-Cavallini E; Gamboa-Coronado MM; Quesada-Gómez C
    Rev Esp Quimioter; 2012 Dec; 25(4):261-5. PubMed ID: 23303257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent.
    Birkenmeyer RD; Kroll SJ; Lewis C; Stern KF; Zurenko GE
    J Med Chem; 1984 Feb; 27(2):216-23. PubMed ID: 6363698
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of ofloxacin (HOE 280) in a model of subcutaneous abscess: penetration and prevention of abscess formation.
    García Iglesias MC; Perea EJ
    Infection; 1986; 14 Suppl 4():S266-9. PubMed ID: 3546146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental aspects of intraabdominal abscess.
    Bartlett JG
    Am J Med; 1984 May; 76(5A):91-8. PubMed ID: 6720740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of experimental Staphylococcus aureus abscesses: comparison of cefazolin, cephalothin, cefoxitin, and cefamandole.
    Kaye D; Parsons JN; Carrizosa J; Kobasa WD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):200-3. PubMed ID: 426513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Host factors in the formation of abscesses.
    Joiner KA; Gelfand JA; Onderdonk AB; Bartlett JG; Gorbach SL
    J Infect Dis; 1980 Jul; 142(1):40-9. PubMed ID: 7400627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of subcutaneous and intraperitoneal abscesses in mice by Neisseria gonorrhoeae and Bacteroides species.
    Brook I
    Am J Obstet Gynecol; 1986 Aug; 155(2):424-9. PubMed ID: 3090882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent sterile abscesses following aluminium adjuvant-containing vaccines.
    Klein NP; Edwards KM; Sparks RC; Dekker CL;
    BMJ Case Rep; 2009; 2009():. PubMed ID: 21686546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Photo Quiz: Pneumonia and Pyogenic Skin Abscesses in a 79-Year-Old Man.
    Held J; Schweizer H; Zange S; Panning M; Kern WV; Wagner D
    J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29367311
    [No Abstract]   [Full Text] [Related]  

  • 60. A PLASMA FIBRINOGEN-INCREASING FACTOR OBTAINED FROM STERILE ABSCESSES IN DOGS.
    Homburger F
    J Clin Invest; 1945 Jan; 24(1):43-5. PubMed ID: 16695186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.